1. Promising new agents in the treatment of non-small cell lung cancer

   • Martin J. Edelman
   • David R. Gandara

   Original Article Pages: 385 - 393

2. Determination of extracellular methotrexate tissue levels by microdialysis in a rat model

   • Per O. Ekstrøm
   • Anders Andersen
   • Lars Slørdal

   Original Article Pages: 394 - 400

3. Formulation and stability of busulfan for intravenous administration in high-dose chemotherapy

   • Harshal P. Bhagwatwar
   • Sasima Phadungpojna
   • Borje S. Andersson

   Original Article Pages: 401 - 408

4. Clinical and experimental pharmacokinetic interaction between 6-mercaptopurine and methotrexate

   • Federico Innocenti
   • Romano Danesi
   • Mario Del Tacca

   Original Article Pages: 409 - 414

5. High-dose 7-hydroxymethotrexate: Acute toxicity and lethality in a rat model

   • Eivind Smeland
   • Ole Martin Fuskevåg
   • Jarle Aarbakke

   Original Article Pages: 415 - 422

6. Cell-cycle arrests and p53 accumulation induced by geldanamycin in human ovarian tumour cells

   • A. J. McIlwrath
   • V. G. Brunton
   • R. Brown

   Original Article Pages: 423 - 428

7. A single-sample assay for the estimation of the area under the free carboplatin plasma concentration versus time curve

   • Saad Ghazal-Aswad
   • A. Hilary Calvert
   • David R. Newell

   Original Article Pages: 429 - 434

8. In vivo antitumor activity of cis-bis-neodecanoato-trans- R,R-l,2-diaminocyclohexane platinum(II) formulated in long-circulating liposomes

   • Atsuhide Mori
   • Su-Ping Wu
   • Leaf Huang

   Original Article Pages: 435 - 444

9. Natural killer cell activity in chronic lymphocytic leukemia patients treated with fludarabine

   • L. E. Robertson
   • A. W. Denny
   • J. A. Nelson

   Original Article Pages: 445 - 450

10. Stereoselective pharmacokinetics of ifosfamide and its 2- and 3-N-dechloroethylated metabolites in female cancer patients

    • Camille P. Granvil
    • Julie Ducharme
    • Irving W. Wainer

    Original Article Pages: 451 - 456

11. Cross-resistance and collateral sensitivity to natural product drugs in cisplatin-sensitive and -resistant rat lymphoma and human ovarian carcinoma cells

    • Hemant Parekh
    • Henry Simpkins

    Original Article Pages: 457 - 462

12. cis-Diamminedichloroplatinum(II)-induced cell death through apoptosis in sensitive and resistant human ovarian carcinoma cell lines

    • Michael G. Ormerod
    • Ciaran O’Neill
    • Kenneth R. Harrap

    Original Article Pages: 463 - 471

13. Pharmacology of N,N-di(n-butyl)adriamycin-14-valerate in the rat

    • Guozhu Han
    • Mervyn Israel
    • Trevor W. Sweatman

    Original Article Pages: 472 - 478

14. The effect of treatment with high dose melphalan, cisplatin or carboplatin on levels of glutathione in plasma, erythrocytes, mononuclear cells and urine

    • Linda Hogarth
    • Martin English
    • Andrew G. Hall

    Original Article Pages: 479 - 485

15. Dependence of fluorodeoxyuridine-induced cytotoxicity and megabase DNA fragment formation on S phase progression in HT29 cells

    • Hsin-yi Y. Tang
    • Kris L. Weber
    • Jonathan Maybaum

    Original Article Pages: 486 - 490

16. Gemcitabine: A phase II study in patients with advanced renal cancer

    • P. H. M. De Mulder
    • L. Weissbach
    • J. Blatter

    Clinical Trial Report Pages: 491 - 495

17. Phase II study of mitomycin, ifosfamide and cisplatin in adenocarcinoma of the oesophagus

    • Simon M. Allen
    • John P. Duffy
    • Hugoe R. Matthews

    Clinical Trial Report Pages: 496 - 498

18. Plasma alcohol concentrations in patients following paclitaxel infusion

    • Lorraine K. Webster
    • Nicholas A. Crinis
    • Michael J. Millward

    Short communication Pages: 499 - 501

19. Effects of granisetron with doxorubicin or epirubicin on ECG intervals

    • Ismo T. Jantunen
    • Vesa V. Kataja
    • Tapani Parviainen

    Short Communication Pages: 502 - 504